SOLTI-1502 ARIANNA: Targeting PAM50 HER2-enriched intrinsic subtype with enzalutamide in hormone receptorpositive/HER2-negative metastatic breast cancer

Simple item page
dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorManso, L.
dc.contributor.authorPernas, S.
dc.contributor.authorMargeli, M.
dc.contributor.authorBlanch, S.
dc.contributor.authorAdamo, B.
dc.contributor.authorSalvador Bofill, F. J.
dc.contributor.authorMoreno, D.
dc.contributor.authorGonzalez, X.
dc.contributor.authorPascual, T.
dc.contributor.authorFerrero-Cafiero, J. M.
dc.contributor.authorPerou, C. M.
dc.contributor.authorPrat, A.
dc.contributor.authorOliveira, M.
dc.contributor.authoraffiliation[Manso, L.] Hosp Univ 12 Octubre, SOLTI Breast Canc Res Grp, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Pernas, S.] ICO Inst Catala dOncol IHosp Hosp Duran, SOLTI Breast Canc Res Grp, Med Oncol Breast Unit, Lhospitalet De Llobregat, Spain
dc.contributor.authoraffiliation[Margeli, M.] Catalan Inst Oncol ICO Badalona, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Blanch, S.] IVO Inst Valenciano Oncol, Med Oncol Dept, Valencia, Spain
dc.contributor.authoraffiliation[Adamo, B.] Hosp Clin Barcelona, Med Oncol Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Salvador Bofill, F. J.] Hosp Univ Virgen Rocio, Dept Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Moreno, D.] Hosp Univ Fdn Alcorcon, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Gonzalez, X.] Hosp Univ Gen Catalunya, Med Oncol Dept, Sant Cugat Del Valles, Spain
dc.contributor.authoraffiliation[Pascual, T.] Univ N Carolina, SOLTI Cooperat Grp, Med Oncol Dept, Chapel Hill, NC, Spain
dc.contributor.authoraffiliation[Ferrero-Cafiero, J. M.] Clin Res Dept, SOLTI HQ, Barcelona, Spain
dc.contributor.authoraffiliation[Perou, C. M.] Univ N Carolina, Lineberger Comprehens Canc, Chapel Hill, NC USA
dc.contributor.authoraffiliation[Prat, A.] Univ Barcelona, Med Oncol Dept, SOLTI Breast Canc Res Grp, IDIBAPS,Hosp Clin Barcelona, Barcelona, Spain
dc.contributor.authoraffiliation[Oliveira, M.] Vall dHebron Univ Hosp, SOLTI Breast Canc Res Grp, Med Oncol Dept, VHIO, Barcelona, Spain
dc.contributor.funderBreast Cancer Research Foundation
dc.date.accessioned2025-01-07T15:33:04Z
dc.date.available2025-01-07T15:33:04Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.622
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.622
dc.identifier.urihttps://hdl.handle.net/10668/27232
dc.identifier.wosID700527700318
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS515-S515
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleSOLTI-1502 ARIANNA: Targeting PAM50 HER2-enriched intrinsic subtype with enzalutamide in hormone receptorpositive/HER2-negative metastatic breast cancer
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía